Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
ACS Medicinal Chemistry Letters|September 24, 2016
Modifications of a Nanomolar Cyclic Peptide Antagonist for the EphA4 Receptor To Achieve High Plasma StabilityErika J Olson, Bernhard C Lechtenberg, Chunxia Zhao, et al.
The Biochemical Journal|June 24, 2009
Recombinant production of eight human cytosolic aminotransferases and assessment of their potential involvement in glyoxylate metabolismStefano Donini, Manuela Ferrari, Chiara Fedeli, et al.
British Journal of Cancer|February 5, 2020
Inhibition of the deubiquitinase USP10 induces degradation of SYKJing Yang, Chengcheng Meng, Ellen Weisberg, et al.
European Journal of Medicinal Chemistry|March 25, 2024
Lipidation and PEGylation Strategies to Prolong the in Vivo Half-Life of a Nanomolar EphA4 Receptor AntagonistMaricel Gomez-Soler, Erika J Olson, Elena Rubio de la Torre, et al.
European Journal of Medicinal Chemistry|November 4, 2024
Lipidation and PEGylation strategies to prolong the in vivo half-life of a nanomolar EphA4 receptor antagonistMaricel Gomez-Soler, Erika J Olson, Elena Rubio de la Torre, et al.
Cell Chemical Biology|October 24, 2017
Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7Ilaria Lamberto, Xiaoxi Liu, Hyuk-Soo Seo, et al.
Analytical Chemistry|February 15, 2017
Leveraging Gas-Phase Fragmentation Pathways for Improved Identification and Selective Detection of Targets Modified by Covalent ProbesScott B Ficarro, Christopher M Browne, Joseph D Card, et al.
Nature Chemical Biology|October 3, 2017
Inhibition of USP10 induces degradation of oncogenic FLT3Ellen L Weisberg, Nathan J Schauer, Jing Yang, et al.
Nature Structural & Molecular Biology|January 20, 2026
Cereblon induces G3BP2 neosubstrate degradation using molecular surface mimicryStefano Annunziato, Chao Quan, Etienne J Donckele, et al.
Pageof 3